SCHEMBL6558375

SCHEMBL6558375

Cc1ccc(C(=O)Cn2cncn2)cc1

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C19 P33261 1/20 0.59
SRC P12931 2/20 0.51
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 1/20 0.48
CYP19A1 P11511 1/20 0.48
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
MAPT P10636 2/20 0.46
HTT P42858 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
POLB P06746 2/20 0.45
HSP90AA1 P07900 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13781424 0.84 HDAC1 (0.50) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL31324468 0.84 EGLN3 (0.54) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL7293623 0.84 HTT (0.63) ALDH1A1KDM4ECYP19A1KMT2AMEN1
SCHEMBL673406 0.84 LMNA (0.53) CYP3A4CYP2C19CYP19A1KMT2AMAPT
SCHEMBL412906 0.84 HDAC1 (0.49) CYP19A1MAPTHTTHDAC1HDAC6
SCHEMBL5066568 0.83 CYP19A1 (0.59) ALDH1A1CYP19A1KMT2AMEN1MAPT
SCHEMBL10559569 0.83 ALDH1A1 (0.55) SRCALDH1A1KDM4EMAPTHTT
Hydrochloric Acid SCHEMBL409501 0.83 HTT (0.61) ALDH1A1KDM4ECYP19A1KMT2AMEN1
Hydrochloric Acid SCHEMBL412860 0.82 CYP19A1 (0.57) ALDH1A1CYP19A1KMT2AMEN1MAPT
SCHEMBL10560674 0.82 CYP1A2 (0.48) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003505-B1 HETEROCYCLIC VINYLETHERS AGAINST NEUROLOGICAL DISORDERS HOFFMANN LA ROCHE (CH) 2004-03-24 EP disclosed
US-6248901-B1 (1-PHENYL-2-CYCLOALKYLOXY-VINYL)-(1,2,4)TRIAZOLES; CONTROL OR PREVENTION OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS. HOFFMAN-LA ROCHE INC. 2001-06-19 US disclosed
US-6054588-A Heterocyclic vinyl ethers HOFFMAN-LA ROCHE INC. (US) 2000-04-25 US disclosed
EP-0431968-B1 Oxetane derivatives, their preparation and their use as anti-fungal or fungicidal agents SANKYO CO (JP) 1995-03-15 EP disclosed
US-5332753-A Thiazole derivatives, their preparation and their use as fungicides SHELL RESEARCH LIMITED (GB) 1994-07-26 US disclosed
US-5134152-A 1,2,4-Triazole compounds SANKYO COMPANY, LIMITED (JP) 1992-07-28 US disclosed
EP-0431968-A1 Oxetane derivatives, their preparation and their use as anti-fungal or fungicidal agents Sankyo Company Limited (JP) 1991-06-12 EP disclosed
EP-0411718-A2 Thiazole derivatives, their preparation and their use as fungicides SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1991-02-06 EP disclosed
US-4767866-A 3-Phenyl-3-(1H-1,2,4-triazol-1-ylmethyl)-2-methyl-5-alkylisoxazolidines PENNWALT CORPORATION (US) 1988-08-30 US disclosed
EP-0183147-A2 Beta-substituted aminophenethylazol derivatives NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1986-06-04 EP disclosed